当前位置: X-MOL 学术J. Transl. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Hsa_circ_0001361 facilitates the progress of lung adenocarcinoma cells via targeting miR-525-5p/VMA21 axis
Journal of Translational Medicine ( IF 6.1 ) Pub Date : 2021-09-10 , DOI: 10.1186/s12967-021-03045-4
Hong-Yu Shen 1 , Liu-Xi Shi 2 , Lin Wang 1 , Le-Ping Fang 1 , Wei Xu 1 , Ju-Qing Xu 1 , Bo-Qiang Fan 3 , Wei-Fei Fan 1
Affiliation  

Lung adenocarcinoma (LUAD) is a common subtype of lung cancer with high recurrence rate and fatality. Circ_0001361 has been recognized as key regulators in various malignancies, but its roles in LUAD remain ambiguous. Circ_0001361, miR-525-5p, and VMA21 levels were assessed by RT-qPCR. The growth and metastasis of LUAD cells were detected by MTT, colony formation, wound scratch, and transwell assays, respectively. The interaction between circ_0001361/VMA21 and miR-525-5p was detected by dual luciferase, RNA immunoprecipitation, and RNA pull-down assays. VMA21 protein level was detected by Western blotting. Nude mouse xenograft model was established to determine the role of circ_0001361 in tumor growth in vivo. Circ_0001361 was up-regulated, while miR-525-5p was down-regulated in LUAD tissues and cells. Functional experiments demonstrated that circ_0001361 drove LUAD cell growth and metastasis. Mechanistically, circ_0001361 functioned as a sponge of miR-525-5p to up-regulate downstream target VMA21 level. MiR-525-5p/VMA21 axis was involved in circ_0001361-mediated malignant phenotypes of LUAD cells. Finally, inhibition of circ_0001361 restrained in vivo xenograft tumor growth via regulating miR-525-5p/VMA21 axis. Our findings elucidate that circ_0001361 facilitates the tumorigenesis and development of LUAD through miR-525-5p/VMA21 axis, providing evidence for circ_0001361 as a potential prognosis biomarker and therapeutic target for clinical treatment of LUAD.

中文翻译:

Hsa_circ_0001361通过靶向miR-525-5p/VMA21轴促进肺腺癌细胞的进展

肺腺癌(LUAD)是一种常见的肺癌亚型,具有较高的复发率和致死率。Circ_0001361 已被公认为各种恶性肿瘤的关键调节剂,但其在 LUAD 中的作用仍然模棱两可。通过 RT-qPCR 评估 Circ_0001361、miR-525-5p 和 VMA21 水平。分别通过MTT、集落形成、伤口划痕和transwell测定法检测LUAD细胞的生长和转移。circ_0001361/VMA21 和 miR-525-5p 之间的相互作用通过双荧光素酶、RNA 免疫沉淀和 RNA 下拉试验检测。通过Western印迹检测VMA21蛋白水平。建立裸鼠异种移植模型以确定circ_0001361在体内肿瘤生长中的作用。Circ_0001361 上调,而 miR-525-5p 在 LUAD 组织和细胞中下调。功能实验表明,circ_0001361 驱动了 LUAD 细胞的生长和转移。机制上,circ_0001361 充当 miR-525-5p 的海绵,以上调下游目标 VMA21 水平。MiR-525-5p/VMA21 轴参与 circ_0001361 介导的 LUAD 细胞恶性表型。最后,抑制 circ_0001361 通过调节 miR-525-5p/VMA21 轴来抑制体内异种移植肿瘤的生长。我们的研究结果阐明了circ_0001361通过miR-525-5p/VMA21轴促进了LUAD的肿瘤发生和发展,为circ_0001361作为临床治疗LUAD的潜在预后生物标志物和治疗靶点提供了证据。MiR-525-5p/VMA21 轴参与 circ_0001361 介导的 LUAD 细胞恶性表型。最后,抑制 circ_0001361 通过调节 miR-525-5p/VMA21 轴来抑制体内异种移植肿瘤的生长。我们的研究结果阐明了circ_0001361通过miR-525-5p/VMA21轴促进了LUAD的肿瘤发生和发展,为circ_0001361作为临床治疗LUAD的潜在预后生物标志物和治疗靶点提供了证据。MiR-525-5p/VMA21 轴参与 circ_0001361 介导的 LUAD 细胞恶性表型。最后,抑制 circ_0001361 通过调节 miR-525-5p/VMA21 轴来抑制体内异种移植肿瘤的生长。我们的研究结果阐明了circ_0001361通过miR-525-5p/VMA21轴促进了LUAD的肿瘤发生和发展,为circ_0001361作为临床治疗LUAD的潜在预后生物标志物和治疗靶点提供了证据。
更新日期:2021-09-12
down
wechat
bug